RxDoctor Payments DataLook up a doctor →

Stephen Yuan, MD

Family Medicine · Suffield, CTNPI 1295754133

Payments from drug & device makers

$16,966in general payments, 2019–2025

Across 991 payments — averaging $17.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$3K
  • GSK$2K
  • Boehringer Ingelheim$1K
  • Novo Nordisk$1K
  • AstraZeneca$1K
  • Amgen$1K
  • plus $8K from 50 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)147$2,596
GSK108$1,766
Boehringer Ingelheim64$1,280
Novo Nordisk75$1,264
AstraZeneca65$1,186
Amgen(2 entities)65$1,114
Sanofi-aventis U.S. LLC55$975
Lilly USA, LLC58$915
Pfizer51$708
Abbott30$491
Supernus Pharmaceuticals, Inc.20$396
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC21$373
Takeda Pharmaceuticals U.S.A., Inc.24$362
Merck26$351
Astellas Pharma US Inc17$278
E.r. Squibb & Sons, L.L.C.17$278
Arbor Pharmaceuticals, Inc.15$274
Johnson & Johnson(2 entities)18$258
Paratek Pharmaceuticals, Inc.11$198
Novartis11$180
Kowa Pharmaceuticals America, Inc.14$172
Esperion Therapeutics, Inc.6$137
Otsuka America Pharmaceutical, Inc.7$124
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)5$112
Collegium Pharmaceutical, Inc.4$85
Exact Sciences4$80
Teva Pharmaceuticals USA, Inc.4$71
Genentech USA, Inc.4$67
Eisai Inc.3$67
Biohaven Pharmaceutical Holding Company Ltd.3$61
Bayer2$58
Idorsia Pharmaceuticals US Inc3$57
Biohaven Pharmaceuticals, Inc.3$57
Amarin Pharma, Inc.3$47
Radius Health, Inc.2$44
Nabriva Therapeutics, PLC3$43
Kyowa Kirin, Inc.2$40
Currax Pharmaceuticals LLC2$34
QOL Medical, LLC1$32
Impel Pharmaceuticals Inc.2$30
Neurocrine Biosciences, Inc.1$30
Actelion Pharmaceuticals US, Inc.1$30
Jazz Pharmaceuticals Inc.1$25
Dexcom, Inc.1$24
Corium, LLC1$23
Mylan Specialty L.p.1$21
Corcept Therapeutics1$20
Acadia Pharmaceuticals Inc1$19
Assertio Therapeutics, Inc.1$19
Welch Allyn1$15
Ultragenyx Pharmaceutical Inc.1$15
Zyla Life Sciences, Inc.1$15
Gilead1$13
Aytu Biopharma, Inc.1$13
Almatica Pharma LLC1$12
Circassia Inc.1$11

How this compares

$16,966 in reported general payments places this provider in the 95th percentile of 588 family medicine providers in Connecticut.

See all family medicine providers in Connecticut →

Medicare billing

Part B allowed, 2024
$98,634
Medicare patients
335
Services billed
1,086

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family medicine in Suffield

See the full list for Connecticut →

Where these figures come from

Is this you, or does something look wrong? →